drugset / Trial / NCT00674154
Effect of Vitamin D Treatment in Primary Hyperparathyroidism
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary aim of the study is to assess whether 6-months of vitamin D supplements can decrease PTH compared with placebo treatment in primary hyperparathyroidism.
Timeline
- Start
- 2008-05
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 2800 iu | Oral |